Details for Patent: 5,519,021

✉ Email this page to a colleague

Summary for Patent: 5,519,021

Patent landscape, scope, and claims:

Title:	Benzoxazinones as inhibitors of HIV reverse transcriptase
Abstract:	Certain benzoxazinones are useful in the inhibition of HIV reverse transcriptase (including its resistant varieties), the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
Inventor(s):	Young; Steven D. (Lansdale, PA), Britcher; Susan F. (Norristown, PA), Payne; Linda S. (Lansdale, PA), Tran; Lekhanh O. (West Chester, PA), Lumma, Jr.; William C. (Pennsburg, PA)
Assignee:	Merck & Co., Inc. (Rahway, NJ)
Application Number:	08/460,026
Patent Claim Types: see list of patent claims	Compound; Use; Composition;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 5,519,021

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 5,519,021

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	0582455	⤷ Subscribe	CA 2001 00014	Denmark	⤷ Subscribe
European Patent Office	0582455	⤷ Subscribe	SPC029/2000	Ireland	⤷ Subscribe
European Patent Office	0582455	⤷ Subscribe	CA 2008 00026	Denmark	⤷ Subscribe
European Patent Office	0582455	⤷ Subscribe	91446	Luxembourg	⤷ Subscribe
European Patent Office	0582455	⤷ Subscribe	08C0021	France	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.